<DOC>
	<DOCNO>NCT00387153</DOCNO>
	<brief_summary>Phase 1 Open-label treatment MPC-2130 subject refractory cancer .</brief_summary>
	<brief_title>Phase 1 Clinical Trial MPC-2130 Treatment Blood Cancers / Refractory Cancer</brief_title>
	<detailed_description>MPC-2130 Phase 1 Clinical study design evaluate safety pharmacokinetic profile patient advance metastatic tumor blood cancer well refractory cancer progress despite previous chemotherapy .</detailed_description>
	<criteria>1 . Be capable understand informed consent form ( ICF ) comply protocol , must sign ICF prior performance study related procedure ; 2 . Have cancer nonresponsive despite prior treatment current standard care regimens available effective therapy ; 3 . Have measurable evaluable neoplastic disease ; 4 . Be great equal age 18 ; 5 . Have ECOG Performance Status score less equal 2 ; 6 . Have adequate organ function define : 1 . Liver function test ( AST &amp; ALT ) less equal 3 time upper limit normal ( ULN ) ; 2 . Bilirubin le equal 1.5 X ULN ; 3 . Serum Creatinine less equal 1.5 X ULN ; 4 . Hemoglobin great equal 8.0 g/dL ; 7 . Have recover stabilize clinically significant toxicity prior chemotherapy , surgery , radiotherapy ; 8 . Have leave ventricular ejection fraction ( LVEF ) great equal 45 % multiple gated acquisition ( MUGA ) scan echocardiogram . 1 . Have prior serious , uncontrollable hypersensitivity reaction Cremophor EL ; 2 . Be pregnant lactating ( woman childbearing potential must use appropriate birth control ( abstinence , barrier method , oral contraceptive and/or intrauterine device ) entire duration study , patient must surgically sterile ( documentation patient 's medical record ) ; 3 . Receive anticancer treatment investigational therapy within 14 day prior day 1 ; within 6 week prior mitomycin C nitrosourea . Patients advanced prostate cancer may continue receive leutinizing hormonereleasing hormone ( LHRH ) therapy study ; 4 . Have previously enrol trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Oncology</keyword>
	<keyword>Cancer</keyword>
	<keyword>Blood Cancers</keyword>
</DOC>